How can the Democratic candidates not bash the drug companies in tonight's presidential debate? How can they not say that there should be price controls or that the government ought to use its buying power to knock down prices? How can the Dems not demonize those execs in the industry who jack up prices on a serial basis?
I was surprised when I saw the biotechs up this morning given that the Democrats know that bashing pharma is a pure vote-getter. Unless you have a family member who pays $400,000 for a drug from BioMarin (BMRN) and is reimbursed, you have to be nodding in agreement if the company gets bashed for its pricing.
Of course the costs to the system without the drugs are much bigger, and the quality of life much worse. No drug company would bother wasting its time on a disease that has only 10,000 victims or fewer.
But does anyone believe that these candidates will bother to look under the hood and figure out which drug companies spend a lot of money on R&D and which ones are just jacking up the price of off-patent drugs that don't have any generic competition?
I don't think so.
To me, you will have to wait until tomorrow to see whether what they say tonight gives you any bargains. Pharma's just too big a target not to bash. So, you have to figure they will do it.